Thank you for making Boston Children’s Global Pediatric Innovation Summit + Awards 2015 the most successful ever.
We hope that you found our keynote speakers dynamic and engaging, our panels informative and insightful and were inspired by the Innovation Tank, Ignite Talks and Rising Star and Lifetime Achievement Awardees.
Please take a few minutes to complete our survey: Take the Survey
The Rising Star Award highlights an emerging innovator whose work has caused or is leading to a breakthrough in pediatric medicine. This award will be presented to Dr. Vijay Sankaran.
The Lifetime Impact Award recognizes a clinician or researcher who has devoted their career to accelerating innovation in pediatric medicine. This award will be present to Dr. Stu Orkin.
For more information see 2015 Pediatric Innovator Awards
High school sophomore Jack Andraka is the developer of an early diagnostic test for pancreatic, ovarian and lung cancer and 2012 recipient of Gordon E. Moore Award, the grand prize of the Intel International Science and Engineering Fair.Jack Andraka:
Peter Waters has been on staff at Boston Children's Hospital since 1989 as the Director of the Hand and Upper Extremity Surgery Program. He is the John E. Hall Professor of Orthopedic Surgery at the Harvard Medical School and became the Orthopedic Surgeon-in-Chief at Boston Children's Hospital in 2013.
As chief of health informatics officer at MITRE, Ms. Tobin provides strategic oversight of health information technology (IT) initiatives across the public and private sectors, including activities in support of the Office of the National Coordinator for Health IT. She leads internally funded innovations that further health data interoperability, patient empowerment, patient safety, and the use of health IT to transform health care.
Dr. Salgo currently serves as Chief, Cardiovascular Investigations and Philips Research Fellow for Ultrasound Research and Development at Philips Healthcare. He has ten years of experience in academic medicine at the University of Pennsylvania in Cardiothoracic Anesthesiology and Intraoperative Echocardiography and has conducted NIH-funded research in cardiac mechanics and imaging.
Dan Cerutti leads special Commercialization efforts for the IBM Watson Group. He led the original start up efforts within IBM to commercialize the Watson Cognitive Computing technologies. He has been intimately involved in most of the Watson for Healthcare initiatives and efforts in the Public Sector. Dan’s current passion is using the breakthrough Watson technologies to help transform healthcare.
Carlos Dominguez is a Senior Vice President in the office of the Chairman and CEO at Cisco, as well as a technology evangelist and social media maven. Dominguez motivates audiences worldwide with engaging, highly-animated presentations full of deep insight into how technology and an adaptable culture can create winning organizations. Drawing on his 21 years at Cisco, his personal connections with thought-leaders around the world, and his wide-ranging curiosity, Dominguez highlights ground-breaking new trends in technology, including the Internet of Everything, the democratization of knowledge, and exciting changes in the retail and social landscape.Carlos Dominugez:
Michael Fisher became president and CEO of Cincinnati Children’s Hospital Medical Center in January 2010. Fisher and his leadership team are expanding the impact of Cincinnati Children’s patient care, education and research activities. Last year, Cincinnati Children’s had nearly 1.2 million patient encounters, serving children from its primary service area of Southwest Ohio, all of the other 49 states and 53 countries.
Dr. William A. Gahl earned his B.S. in biology from the Massachusetts Institute of Technology in 1972 and his M.D. from the University of Wisconsin in 1976. He obtained a Ph.D. degree in oncology research from Wisconsin’s McArdle Laboratories for Cancer Research in 1981 and served as pediatric resident and chief resident at the University of Wisconsin hospitals from 1976-80. In 1984, he completed Clinical Genetics and Clinical Biochemical Genetics fellowships.
Dr. Mansoor Khan, Sc.D. MIT, Chief Executive Officer and Co-Founder of Alere Analytics, has over 20 years of technical information technology and management experience in multiple industries. Dr. Khan earned his Doctor of Science degree at MIT in 1988 and prior to that, a B.S. and M.S. from Auburn University, where he worked on Predictive Modeling. He started his career at MIT as a research scientist. Prior to founding DiagnosisOne, now Alere Analytics, Dr. Khan was Founder and CEO of KeyCommerce, where he took the company from a start-up to an established player in the electronic commerce industry whose customers included companies such as Sun Microsystems and Raytheon.
In 2012, Kass-Hout co-chaired the White House Office of Science and Technology Policy (OSTP) Biosurveillance sub-committee dealing with “detecting disease and threat aberrations from the norm.” He is credited with launching the first DHHS program completely operational in the Internet cloud (2010), in alignment with the White House Cloud Initiative resulting in significant savings in overhead costs (>95% of the original investment) to CDC and state and local health jurisdictions and governments. In turn, and since 2011, these savings continue to support creation of additional jobs at all levels of the government for increased public health disease surveillance, situation awareness and response.Taha Kass-Hout:
Daniel Nigrin is the Senior VP of Information Services and Chief Information Officer at Boston Children’s Hospital. His research interests include development of web-based patient- provider communication systems, especially for patients with chronic diseases like diabetes mellitus, and development and implementation of large-scale electronic medical record systems, including implementation of medication error reduction techniques through use of technology. Dr. Nigrin also has significant experience in creation of easy to use tools to facilitate data mining of large clinical databases, for both research and clinical care purposes.
Albert Seymour is a human geneticist with more than 17 years of scientific and leadership experience in drug discovery and development. He is currently Vice President of Drug Discovery and Translational Research at Shire where he is responsible for the Discovery and Early Development of novel therapeutics for the treatment of patients with rare diseases. Prior to joining Shire, Albert held various leadership positions at Pfizer where his team applied human genetics and computational biology to discover and develop novel therapeutics targeting diabetes, inflammatory diseases, and cancer.
Halle Tecco is a Founder & Managing Director of Rock Health, the first seed fund devoted exclusively to digital health companies. Tecco recognized the need and potential for startups in the space while working at Apple's App Store covering the health and medical vertical. With her husband, she is also an angel investor in over 30 technology companies including Misfit Wearables, Quora, and Kaggle.Hallee Tecco:
Henry Wei, MD is the Aetna Innovation Labs’ Senior Medical Director for Clinical Innovation. Dr. Wei recently served with the White House as an inaugural Presidential Innovation Fellow. Henry is a faculty member in Internal Medicine at Cornell (Weill Medical College). Prior to his role at Aetna, Henry served as Sr. Medical Director for Clinical R&D at ActiveHealth Management. He has worked as a consultant in the healthcare practice of McKinsey & Company.Henry Wei: